LinkGevity Awarded Innovate UK Smart Grant for Anti-Necrotic TM Research to Prevent Kidney Deterioration
London, UK, 4 March 2025 – LinkGevity, an AI-driven drug discovery company focused on revolutionising the treatment of ageing, today announces it has been awarded a Smart Grant by the National Innovation Agency of the UK Government, Innovate UK. The Smart Grant will be used in a one-year project involving the company’s Anti-NecroticTM technology, specifically around acute tubular necrosis (ATN), which is a leading cause of kidney dysfunction, degeneration and ageing. Financial details are not disclosed.
